Chuang et al., 2020 - Google Patents
Annealing-modulated nanoscintillators for nonconventional X-ray activation of comprehensive photodynamic effects in deep cancer theranosticsChuang et al., 2020
View HTML- Document ID
- 14635258592288003663
- Author
- Chuang Y
- Chu C
- Cheng S
- Liao L
- Chu T
- Chen N
- Paldino A
- Hsia Y
- Chen C
- Lo L
- Publication year
- Publication venue
- Theranostics
External Links
Snippet
Photodynamic therapy (PDT), which involves the generation of reactive oxygen species (ROS) through interactions of a photosensitizer (PS) with light and oxygen, has been applied in oncology. Over the years, PDT techniques have been developed for the treatment of deep …
- 201000011510 cancer 0 title abstract description 26
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/285—Arsenic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chuang et al. | Annealing-modulated nanoscintillators for nonconventional X-ray activation of comprehensive photodynamic effects in deep cancer theranostics | |
| Cline et al. | Nanoparticles to mediate X‐ray‐induced photodynamic therapy and Cherenkov radiation photodynamic therapy | |
| Kamkaew et al. | Scintillating nanoparticles as energy mediators for enhanced photodynamic therapy | |
| Larue et al. | Using X-rays in photodynamic therapy: an overview | |
| Hu et al. | Nanocomposite‐based photodynamic therapy strategies for deep tumor treatment | |
| US10646570B2 (en) | Induced photodynamic therapy using nanoparticle scintillators as transducers | |
| Li et al. | Emerging nanotherapeutics for facilitating photodynamic therapy | |
| Zhang et al. | Marriage of scintillator and semiconductor for synchronous radiotherapy and deep photodynamic therapy with diminished oxygen dependence | |
| He et al. | Recent progress and trends in X-ray-induced photodynamic therapy with low radiation doses | |
| Yan et al. | Progress in light‐responsive lanthanide nanoparticles toward deep tumor theranostics | |
| Du et al. | Design of TPGS-functionalized Cu 3 BiS 3 nanocrystals with strong absorption in the second near-infrared window for radiation therapy enhancement | |
| Shan et al. | Near‐Infrared II Plasmonic Phototheranostics with Glutathione Depletion for Multimodal Imaging‐Guided Hypoxia‐Tolerant Chemodynamic‐Photocatalytic‐Photothermal Cancer Therapy Triggered by a Single Laser | |
| Yu et al. | Neodymium‐sensitized nanoconstructs for near‐infrared enabled photomedicine | |
| Sun et al. | MnO 2 nanoflowers as a multifunctional nano-platform for enhanced photothermal/photodynamic therapy and MR imaging | |
| Zhang et al. | Low-dose x-ray excited photodynamic therapy based on naluf4: Tb 3+–rose bengal nanocomposite | |
| Hu et al. | X-ray-excited super-long green persistent luminescence from Tb3+ monodoped β-NaYF4 | |
| Cai et al. | Polypyrrole-coated UCNPs@ mSiO 2@ ZnO nanocomposite for combined photodynamic and photothermal therapy | |
| Naher et al. | Upconversion nanoparticles (UCNPs): Synthesis methods, imaging and cancer therapy | |
| Macchi et al. | Enhanced photothermal heating and combination therapy of NIR dye via conversion to self-assembled ionic nanomaterials | |
| Liu et al. | Cerenkov radiation-activated probes for deep cancer theranostics: a review | |
| Orsi et al. | New CeF3–ZnO nanocomposites for self-lighted photodynamic therapy that block adenocarcinoma cell life cycle | |
| Zhang et al. | Rare-earth scintillating nanoparticles for X-ray induced photodynamic therapy | |
| Zhang et al. | Utilizing dual-pathway energy transfer in upconversion nanoconjugates for reinforced photodynamic therapy | |
| Pan et al. | Gold Nanocage-Based Multifunctional Nanosensitizers for Programmed Photothermal/Radiation/Chemical Coordinated Therapy Guided by FL/MR/PA Multimodal Imaging | |
| Cline et al. | Nanoscintillator-based X-ray-induced photodynamic therapy |